Literature DB >> 12207600

Psoriasis: response to high-dose intravenous immunoglobulin in three patients.

V Gurmin1, R Mediwake, M Fernando, S Whittaker, M H A Rustin, H L C Beynon.   

Abstract

Treatment of recalcitrant psoriasis and psoriatic arthritis can be challenging, with treatment options limited by drug intolerance or poor efficacy. High-dose intravenous immunoglobulin (hdIVIg) has been used successfully in Kawasaki's disease and idiopathic thrombocytopenic purpura, where it has become the standard treatment. The literature also suggests its positive effect in the treatment of dermatological conditions, such as autoimmune chronic urticaria, atopic dermatitis, scleromyxoedema, dermatomyositis and autoimmune bullous disorders. We report three patients with treatment-resistant psoriasis and psoriatic arthritis who improved with hdIVIg.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12207600     DOI： 10.1046/j.1365-2133.2002.04753.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 2.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

3.  A New Kid on the Block: IL-10+ Regulatory B Cells and a Possible Role In Psoriasis.

Authors:  Kamruz Darabi; Rohit Jaiswal; Sarah G Hostetler; Mark A Bechtel; Matthew J Zirwas; Patricia Witman
Journal:  J Pediatr Pharmacol Ther       Date:  2009-07

4.  Effect of Adalimumab on Gene Expression Profiles of Psoriatic Skin and Blood.

Authors:  Maggie Chow; Kevin Lai; Richard Ahn; Rashmi Gupta; Sarah Arron; Wilson Liao
Journal:  J Drugs Dermatol       Date:  2016-08-01       Impact factor: 2.114

Review 5.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

6.  Immunotherapy using Histobulin™ in psoriasis: A case report.

Authors:  Hyuk Soon Kim; Geunwoong Noh
Journal:  Clin Case Rep       Date:  2022-05-12

7.  Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies.

Authors:  Hartwig W Lehmann; Annelie Plentz; Philipp Von Landenberg; Esther Müller-Godeffroy; Susanne Modrow
Journal:  Arthritis Res Ther       Date:  2003-10-10       Impact factor: 5.156

8.  Myelin-associated glycoprotein-related neuropathy associated with psoriasis: a case report.

Authors:  Ken-Ya Murata; Hideto Miwa; Tomoyoshi Kondo
Journal:  J Med Case Rep       Date:  2013-01-03

9.  Psoriasis: An Unusual Autoimmune Manifestation in a Boy with Common Variable Immunodeficiency.

Authors:  Ankur Kumar Jindal; Amit Rawat; Avinash Sharma; Sunil Dogra; Deepti Suri; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2017 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.